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Infective endocarditis can be a devastating disease. Embolic
events, particularly strokes, are dreaded complications that
often leave persistent disability after the infection is success-
fully treated. Despite advances in surgical techniques and
antibiotic therapy, the incidence of embolism remains about
30% to 40% and has been unchanged over the last 10 to
20 years. Consequently, clinicians are often faced with the
dilemma of whether to try to avoid embolic complications
by intervening surgically or to treat medically and wait. To
date there are no clear answers, as established criteria for
surgery are based on heart failure, unresolving infection and
recurrent emboli. Interventions are often too late to prevent
the destructive effects of the first major embolic event.
Researchers have tried to identify factors that predispose to
embolic events, with the hope of using these predictors to
select patients for early intervention and reduce the inci-
dence of severe embolic episodes.
See page 1069
The article by Di Salvo et al. (1) in this issue of the
Journal examines the echocardiographic predictors of em-
bolic events in infective endocarditis. The study population
at this tertiary care center consisted of 178 consecutive
patients with definite endocarditis as established by the
Duke criteria. The patients were evaluated with multiplane
transesophageal echocardiograms to accurately assess the
echocardiographic characteristic of the vegetations. The
patients underwent prospective screening for emboli using
computed tomography (CT) scans of the abdomen, thorax
and head. The echocardiographic features of the lesions,
including size, location and mobility, the demographic
features of the patients and the bacteriological features of
the infection were all compared using univariate and mul-
tivariate analyses to determine the relationship among these
features and the occurrence of embolic events. The study
concludes that both the size of the vegetations and their
mobility were related to the incidence of embolic events.
Patients with vegetations .10 mm had a 60% incidence of
emboli. Patients with severely mobile vegetations .15 mm
had an 83% incidence and were at the greatest risk. This
observation held up in multivariate analysis. The investiga-
tors conclude that the morphologic characteristics of the
vegetations may predict an embolic event and that early
preventive surgery might be warranted in these patients.
The large number of patients and the use of transesophageal
echocardiograms increase the importance of the findings.
However, there are problems and provisos, many of
which the investigators themselves point out. Although
some studies supported the findings of Di Salvo et al. (1)
and reported a significant association between the morpho-
logical characteristics of the vegetative lesion and the prob-
ability of an embolic event (2–4), others did not find such a
relationship (5). To some extent the controversy might be
due to selection bias or the different design of the studies.
However, Di Salvo et al. (1) themselves demonstrated that
factors independent of the echocardiographic appearance of
the vegetation might be associated with the occurrence of an
embolic event—for example, the infecting organism (Staph-
ylococcus aureus). Many of the patients underwent valve
replacement or repair early in their hospital course and,
therefore, the effect of treatment in altering outcome cannot
be assessed.
The timing of the occurrence of the emboli is also
unclear. Moreover, 14 of the 66 emboli were asymptomatic,
limiting the role of any preventive measures. At what time
point in the course of the disease were the emboli present—
before initiation of therapy or after antibiotic treatment?
The CT evaluations for emboli were not repeated during
the course of treatment. Thus, only a snapshot was obtained
of the clinical events. This has implications for designing
treatment strategies. The right-sided emboli (9 of 66 overall
embolic events) were not assessed by spiral CT angiogram
or pulmonary angiogram but rather by chest CT. This raises
questions about the interpretation of the pulmonary find-
ings. Differentiating between emboli and metastatic infec-
tions in the lung is difficult. Of concern, a significant
number of patients without vegetations had evidence of
emboli. Embolic events occurred in 20% of the patients in
whom vegetations could not be detected by echocardiogra-
phy. These occurrences might be a result of embolization of
the macroscopic portion of the vegetation or due to vege-
tations adherent to nonvalvular cardiac structures.
However, this finding suggests that embolic events might
occur independently of vegetation size and mobility in a
substantial number of patients. This phenomenon has also
been reported in other studies and has occurred in patients
who suffered strokes after the echocardiographic investiga-
tion. It also suggests that other factors impact the occur-
rence of emboli and that the appearance or size and mobility
alone is not enough. Are there biological factors that might
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be related to the occurrence of emboli and, when used in
conjunction with echocardiographic features, might increase
predictive power? Do therapies that reduce vegetation size
decrease the incidence of emboli?
Thus, the potential limitations of predicting embolic
events by the sole use of echocardiographic parameters led
us to consider or try to identify these other factors. Impor-
tantly, the study by Di Salvo et al. (1) provided a parameter
that is independent of the vegetations’ morphological char-
acteristics but significantly impacts the frequency of embolic
events (S. aureus as the causative micro-organism). Perhaps
distinct bacterial characteristics and virulence mechanisms
(e.g., binding of the organism to the component constitu-
ents of the vegetation, exotoxin production, etc.) might
impact the frequency of embolic events. Bacterial-platelet
interactions or bacterial-endothelium interactions might
play a key role in this respect. Several studies have shown
that the capacity of selected endocarditis pathogens to
initiate platelet aggregation in vitro parallel their propensity
to induce endocarditis in vivo (6,7). Other studies reported
that the staphylococcal in vitro susceptibility to small,
cationic, endogenous peptides with potent microbicidal
activity, termed platelet microbicidal proteins, are significantly
associated with embolic events and bacterial hematogenous
dissemination in experimental S. aureus endocarditis (8,9).
Whether these endogenous peptides have a clinical role
remains to be shown.
Other cellular factors not addressed in the current study
may also need to be considered. Several investigations have
demonstrated that systemic bacterial infections, even in the
absence of cardiac involvement, represent an independent
risk factor for an embolic event (10,11). Inflammation-
induced procoagulant changes and endothelial cell activa-
tion appear to play a major role in this setting. Antiphos-
pholipid antibodies may have an impact on the occurrence
of embolic episodes in infection-related events (12). In this
context, infective endocarditis differs from other infectious
diseases due to the presence of cardiac vegetations as an
additional independent risk factor for an embolic event.
Antiphospholipid antibodies, coagulation parameters and
endothelial cell activation have recently been reported to be
substantially associated with the risk for an embolic event in
infective endocarditis (12,13). The limitation in predicting
embolic events by transesophageal echocardiography was
demonstrated in a subgroup of patients lacking such an-
tiphospholipid antibodies who demonstrated larger vegeta-
tions but did not show an elevated risk for embolic events.
To take the question of biological factors further, are
there opportunities to intervene therapeutically using our
knowledge that some of these cell-mediated factors in
endocarditis influence the biology of the embolic process? A
potential therapeutic approach in patients with infective
endocarditis and vegetative lesions might be the use of
aspirin. Platelets are a key component of vegetations.
Therefore, platelet inhibition might diminish vegetation
evolution and embolic frequency in infective endocarditis.
In several studies using animal models mirroring clinical S.
aureus endocarditis, aspirin was shown to significantly re-
duce vegetation size (14), vegetation bacterial density (15)
and the incidence of embolization (16). However, it remains
to be shown whether these effects can only be found in S.
aureus endocarditis or whether they exist in endocarditis
caused by different pathogens.
Moreover, whether aspirin has a prophylactic role in the
prevention of endocarditis-induced embolic events is an
open question. Good clinical data on this issue are scarce.
An initial observational study indicated a trend toward a
salutary influence of aspirin in endocarditis (17), whereas a
recent prospective Canadian trial showed no favorable
effects but an increase in bleeding events in patients who
received 325 mg per day of aspirin (18). Thus, the thera-
peutic benefit of altering the biological processes that affect
vegetation size and fragility may have untoward conse-
quences (e.g., bleeding). Identifying factors that affect the
incidence of emboli may not help in identifying the type of
therapeutic intervention that would best be undertaken to
avoid emboli. Removing a vegetation based on echocardio-
graphic appearance may not be beneficial. Even if chemical
or biological features of the vegetation are as important as
size in determining propensity to embolize, knowing how to
utilize these insights is unclear.
Di Salvo et al. (1) have given support to the ocular
reflex—large vegetations that look bad are bad. It still
remains to be determined whether early surgical interven-
tion will prevent emboli and improve outcomes. It also
remains to be determined how to combine the findings of
Di Salvo et al. with the cell biology.
Therefore, it seems important to develop cooperative
multicenter studies designed to link morphology and biol-
ogy to answer questions relating these factors to therapy.
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